INSMED Inc — Director's Dealing 2024

Dec 20, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2024-12-19

Reporting Person: Lewis William (Director, Chair and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-19	Common Stock	M	18750	$22.76	Acquired	403710	Direct
2024-12-19	Common Stock	S	13162	$69.65	Disposed	390548	Direct
2024-12-19	Common Stock	S	5588	$70.52	Disposed	384960	Direct
2024-12-19	Common Stock	M	6830	$10.85	Acquired	240754	Indirect
2024-12-19	Common Stock	S	5240	$69.71	Disposed	235514	Indirect
2024-12-19	Common Stock	S	1590	$70.61	Disposed	233924	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-12-19	Stock Option (right to buy)	$22.76	M	18750	Disposed	2025-05-21	Common Stock (18750)	Direct
2024-12-19	Stock Option (right to buy)	$10.85	M	6830	Disposed	2026-05-19	Common Stock (6830)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	50500	Indirect

Footnotes

F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2: This is the weighted average sales price representing 13,162 shares sold at prices ranging from $69.22 to $70.22 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F3: This is the weighted average sales price representing 5,588 shares sold at prices ranging from $70.23 to $70.91 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F4: This is the weighted average sales price representing 5,240 shares sold at prices ranging from $69.28 to $70.27 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F5: This is the weighted average sales price representing 1,590 shares sold at prices ranging from $70.36 to $70.91 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

F6: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.